ASXL1 was the most frequently mutated gene at diagnosis across pediatric (2/16; 13%), AYA (12/80; 15%), and adult (10/97; 10%) CML patients. This evidence concerns the gene ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive.